Samir R. Patel - Director at Akari Therapeutics Plc

Issuer-level insider activity

Role: Director
Issuer ticker: AKTX on Nasdaq
Entity type: Individual
Source filing history: Open source filing history

Past-year transaction volume for Samir R. Patel in Akari Therapeutics Plc

Buys

Open market

Shares: +850,655
Avg price: $0.4041
Total value: +$343,750

Sells

Open market

Shares
Avg price
Total value

Net

Past year

Shares: +850,655
Share %: 100%
Total value: +$343,750

Reported holdings for Samir R. Patel in Akari Therapeutics Plc

Form 4 holding Director

Akari Therapeutics Plc

Security class: American Depositary Shares representing Ordinary Shares
Shares / value: 98,241
Estimated value: $3,394,726
Report date: 07 Jul 2026
Price: $1.12
Ownership: PranaBio Investments LLC

Form 4 holding Director

Akari Therapeutics Plc

Security class: Ordinary Shares, par value $0.0001 per share
Shares / value: 5,249,511,500
Estimated value: $3,149,707
Report date: 03 Jan 2025
Price: $0.000600
Ownership: PranaBio Investments LLC

Form 4 holding Director

Akari Therapeutics Plc

Security class: Series A Warrants (Right to Buy)
Shares / value: 406,250
Estimated value: $455,000
Report date: 06 Mar 2025
Price: $1.12
Ownership: PranaBio Investments LLC
Underlying class: American Depositary Shares representing Ordinary Shares
Underlying amount

Form 4 holding Director

Akari Therapeutics Plc

Security class: Series B Warrants (Right to Buy)
Shares / value: 406,250
Estimated value: $455,000
Report date: 06 Mar 2025
Price: $1.12
Ownership: PranaBio Investments LLC
Underlying class: American Depositary Shares representing Ordinary Shares
Underlying amount

Form 4 holding Director

Akari Therapeutics Plc

Security class: Pre-Funded Warrants to purchase ADRs
Shares / value: 618,658
Estimated value: $249,999
Report date: 16 Dec 2025
Price: $0.4041
Ownership: Direct
Underlying class: American Depositary Shares representing Ordinary Shares
Underlying amount

Form 4 holding Director

Akari Therapeutics Plc

Security class: Pre-Funded Warrants to purchase ADRs
Shares / value: 231,997
Estimated value: $93,749
Report date: 16 Dec 2025
Price: $0.4041
Ownership: PranaBio Investments LLC
Underlying class: American Depositary Shares representing Ordinary Shares
Underlying amount

Form 4 holding Director

Akari Therapeutics Plc

Security class: Ordinary Shares, par value $0.0001 per share
Shares / value: 91,396,000
Estimated value: $54,838
Report date: 03 Jan 2025
Price: $0.000600
Ownership: Direct

Form 4 holding Director

Akari Therapeutics Plc

Security class: American Depositary Shares representing Ordinary Shares
Shares / value: 12,102
Estimated value: $51,182
Report date: 05 Oct 2026
Price: $1.12
Ownership: Direct

Form 4 holding Director

Akari Therapeutics Plc

Security class: Warrants to purchase American Depositary Shares ("ADRs")
Shares / value: 618,658
Estimated value
Report date: 16 Dec 2025
Price
Ownership: Direct
Underlying class: American Depositary Shares representing Ordinary Shares
Underlying amount

Form 4 holding Director

Akari Therapeutics Plc

Security class: Warrants to purchase ADRs
Shares / value: 231,997
Estimated value
Report date: 16 Dec 2025
Price
Ownership: PranaBio Investments LLC
Underlying class: American Depositary Shares representing Ordinary Shares
Underlying amount

Form 4 holding Director

Akari Therapeutics Plc

Security class: Stock Option (Right to Buy)
Shares / value: 15,000
Estimated value
Report date: 18 Aug 2026
Price
Ownership: Direct
Underlying class: American Depositary Shares representing Ordinary Shares
Underlying amount

Form 4 holding Director

Akari Therapeutics Plc

Security class: Pre-Funded Warrant to purchase ADSs
Shares / value: 0
Estimated value
Report date: 07 Jul 2026
Price
Ownership: PranaBio Investments LLC
Underlying class: American Depositary Shares representing Ordinary Shares
Underlying amount

Form 4 holding Director

Akari Therapeutics Plc

Security class: Pre-Funded Warrant to purchase American Depositary Shares
Shares / value: 0
Estimated value
Report date: 07 Jul 2026
Price
Ownership: PranaBio Investments LLC
Underlying class: American Depositary Shares representing Ordinary Shares
Underlying amount

Transaction history for Samir R. Patel in Akari Therapeutics Plc

Sym	Class	Transaction	%	SEC-reported value	SEC-reported price	Shares	Shares after	Date	Ownership

^* marks a reported price that did not pass the local price check.